Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Assembly Biosciences
ASMB
$536M
| $769K | ﹤0.01% |
4,320
-12,692
| -75% | -$2.72M |
|
2552
Lisata Therapeutics
LSTA
$10.6M
| $769K | ﹤0.01% |
28,465
+1,038
| +4% | +$40.3K |
|
|
SGMA
2553
DELISTED
Sigmatron International
SGMA
| $767K | ﹤0.01% |
259,864
-13,064
| -5% | -$46.6K |
|
|
HWCC
2554
DELISTED
Houston Wire & Cable Company
HWCC
| $767K | ﹤0.01% |
350,277
+41,925
| +14% | +$144K |
|
|
STML
2555
DELISTED
Stemline Therapeutics, Inc.
STML
| $766K | ﹤0.01% |
+158,213
| New | +$1.03M |
|
|
UCTT
2556
Ultra Clean Holdings
UCTT
$4.21B
| $765K | ﹤0.01% |
+55,400
| New | +$1.18M |
|
2557
Lear
LEA
$8.16B
| $764K | ﹤0.01% |
9,400
-81,100
| -90% | -$9.34M |
|
|
HHR
2558
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $764K | ﹤0.01% |
+47,822
| New | +$1M |
|
2559
Innodata
INOD
$2.03B
| $763K | ﹤0.01% |
953,337
-9,816
| -1% | -$10.8K |
|
2560
VanEck Oil Services ETF
OIH
$1.95B
| $763K | ﹤0.01% |
9,495
+8,440
| +800% | +$1.57M |
|
2561
Transcat
TRNS
$888M
| $763K | ﹤0.01% |
28,786
-400
| -1% | -$12K |
|
|
FCBP
2562
DELISTED
First Choice Bancorp Common Stock
FCBP
| $761K | ﹤0.01% |
50,698
+198
| +0.4% | +$4.44K |
|
2563
Jakks Pacific
JAKK
$288M
| $760K | ﹤0.01% |
217,705
+1,237
| +0.6% | +$9.61K |
|
|
ASNA
2564
DELISTED
Ascena Retail Group, Inc.
ASNA
| $760K | ﹤0.01% |
547,037
+163,200
| +43% | +$702K |
|
2565
Chord Energy
CHRD
$7.35B
| $759K | ﹤0.01% |
2,168,800
-1,045,831
| -33% | -$1.92M |
|
|
BBU
2566
DELISTED
Brookfield Business Partners
BBU
| $758K | ﹤0.01% |
46,428
-278,128
| -86% | -$6.75M |
|
2567
Xeris Biopharma Holdings
XERS
$1.52B
| $756K | ﹤0.01% |
+387,516
| New | +$1.67M |
|
2568
ProShares Short 20+ Year Treasury ETF
TBF
$106M
| $754K | ﹤0.01% |
48,600
+26,800
| +123% | +$475K |
|
|
FWDI
2569
Forward Industries Inc
FWDI
$305M
| $752K | ﹤0.01% |
67,788
-2,543
| -4% | -$27.1K |
|
|
LL
2570
DELISTED
LL Flooring Holdings, Inc.
LL
| $749K | ﹤0.01% |
159,800
+103,300
| +183% | +$809K |
|
2571
Sonida Senior Living
SNDA
$1.88B
| $745K | ﹤0.01% |
85,621
+1,600
| +2% | +$54.7K |
|
2572
Alto Ingredients
ALTO
$315M
| $742K | ﹤0.01% |
2,852,491
+79,604
| +3% | +$41.9K |
|
2573
Avita Medical
RCEL
$251M
| $740K | ﹤0.01% |
+23,880
| New | +$989K |
|
|
CBIO
2574
Crescent Biopharma
CBIO
$610M
| $738K | ﹤0.01% |
+3,236
| New | +$1.24M |
|
2575
iShares Latin America 40 ETF
ILF
$3.69B
| $738K | ﹤0.01% |
+40,400
| New | +$1.14M |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.